Micralyne and University of Alberta Win Spot on 2007 MICRO/NANO 25 Innovative Product List

Micralyne Inc., a world leading independent MEMS (Micro-Electro-Mechanical-Systems) microfabrication company, and its GLAD (GLancing Angle Deposition) technology, developed in collaboration with Dr. Michael Brett at the University of Alberta, has been selected by R&D Magazine as one of the top 25 MICRO/NANO innovative products for 2007.

An independent panel of experts and the editors of MICRO/NANO Newsletter selected the top 25 micro- and nanotechnologies of 2007. The award winning products, processes, and innovations were those groundbreaking technologies likely to have a large impact on their specific industries and society.

GLAD, developed at both Micralyne and the University of Alberta, is a proprietary physical vapor deposition (PVD) technology used to fabricate porous thin films composed of engineered nanostructures. Its inherent advantage is the ability to create complex nanostructures in a single step process using a simple set of fabrication tools to optimize properties such as surface area, porosity, and composition. GLAD can also be used as the foundation of many value-added next-generation products, from gas sensors and chemical devices to optical polarization filters.

"We expect GLAD will be a platform materials technology suitable for a wide range of device applications" said Dr. Michael Brett, Industrial Research Chair of Thin Film Engineering at the University of Alberta.

"GLAD is truly an innovative technology that has been developed by talented people both at the University of Alberta and at Micralyne" said Chris Lumb, President & CEO of Micralyne.  "This award win demonstrates the excellent potential of GLAD and we believe this technology will serve as a new growth platform that will complement our growing MEMS manufacturing business."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.